Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer (CBCRT01)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Xijing Hospital.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Xijing Hospital Identifier:
First received: October 26, 2011
Last updated: November 21, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)